title: Treatment of patients with advanced cancer using tumor-infiltrating lymphocytes and interleukin 2.
authors.affiliation: Department of Medicine, Massachusetts General Hospital, Boston 02114.
authors.forename: R
authors.initials: R
authors.lastname: Kradin
authors.forename: S
authors.initials: S
authors.lastname: Dubinett
authors.forename: J
authors.initials: J
authors.lastname: Mullin
authors.forename: L
authors.initials: L
authors.lastname: Boyle
authors.forename: H W
authors.initials: HW
authors.lastname: Strauss
authors.forename: P M
authors.initials: PM
authors.lastname: Bourgoin
authors.forename: F I
authors.initials: FI
authors.lastname: Preffer
authors.forename: J
authors.initials: J
authors.lastname: Kurnick
mesh_terms: D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008214:Lymphocytes / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
chemical_list: D007376:Interleukin-2